文献速递主动脉疾病

Anaconda开窗支架近端密封系统治疗复杂腹主动脉瘤的中期结果

Mid-term Results of the Anaconda Fenestrated Stent-Graft Proximal Sealing System in the Exclusion of Complex Abdominal Aortic Aneurysms.
PubMed 文献 · J Endovasc Ther · 2026-01-16

本研究回顾性纳入111例复杂腹主动脉瘤患者,评估Anaconda开窗支架近端密封系统的疗效与耐久性。随访28.1±16.2个月,无 primary type Ia内漏,仅1例发生secondary type Ia内漏;近端瘤颈扩张常见(36%),有效oversizing是唯一独立预测因子。结论提示该系统中期密封性能良好,近端扩张多在第一年后稳定。

要点

  • Anaconda开窗支架近端密封系统中期type Ia内漏发生率低。
  • 近端瘤颈扩张常见,有效oversizing是其独立预测因子。
  • 近端扩张多在第一年后稳定,进展需考虑主动脉疾病。

核心结论

  • Anaconda开窗支架近端密封系统在复杂腹主动脉瘤中显示出良好的中期密封性能,type Ia内漏发生率低。
  • 近端瘤颈扩张与支架oversizing相关,但通常在第一年后稳定,进展者可考虑近端延伸。

研究设计与样本

  • 单中心回顾性研究,纳入2018年1月至2023年5月连续111例接受Anaconda开窗支架治疗的复杂腹主动脉瘤患者。
  • 平均年龄72±7.6岁,男性86%;近肾动脉瘤69例(62.2%),肾旁动脉瘤23例(20.7%),EVAR后近端I型内漏19例(17.1%)。

主要发现

  • 平均随访28.1±16.2个月,出院时无primary type Ia内漏。
  • 随访期间1例(<1%)发生secondary type Ia内漏,经主动脉cuff成功处理。
  • 近端瘤颈扩张(≥3 mm)见于40例(36%),显著支架迁移(>10 mm)见于1例(0.9%),未影响近端密封或桥接支架。
  • 多变量分析显示有效oversizing是近端瘤颈扩张的唯一独立预测因子(OR=1.193;95%CI 1.104-1.288;p<0.001)。
  • 7例(6.3%)接受了预防性近端密封区相关再干预,平均间隔26.4±16.9个月。

关键数值与推荐

  • 近端瘤颈扩张定义为≥3 mm,支架迁移定义为>10 mm。
  • 有效oversizing根据支架名义直径与术后CT血管造影上近端瘤颈水平平均主动脉直径计算。
  • 预防性再干预用于防止type Ia内漏发生。

临床怎么用

  • 在健康腹腔干以上锚定区植入并确保足够有效oversizing时,该装置可提供持久近端密封。
  • 需注意释放技术以避免使用 repositioning system 及相关的ring tilting风险。
  • 早期近端瘤颈扩张常见但多稳定,可个体化监测并在必要时预防性近端延伸。

局限性

  • 单中心回顾性研究设计。
  • 样本量有限(111例),随访时间中等(平均28.1个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Mid-term data on the Anaconda fenestrated stent-graft remain scarce in the literature. OBJECTIVE: The aim of this study was to evaluate the efficacy and durability of its Z-stent-free proximal sealing system. METHODS: All consecutive patients treated between January 2018 and May 2023 with the Anaconda Fenestrated stent-graft (Vascutek/Terumo, Scotland, UK) for complex abdominal aortic aneurysm (AAA) were retrospectively included in this monocentric study. The primary outcome was the occurrence of type Ia endoleak (EL). The secondary outcome was the evolution of the proximal sealing zone (PSZ), defined as proximal neck dilatation (PND) ≥3 mm, stent-graft migration (>10 mm), or the need for PSZ-related reintervention. Effective oversizing (OS) was calculated from the nominal stent-graft diameter and the mean aortic diameter at the PNR level on postoperative computed angiography (CT) angiography. RESULTS: A total of 111 patients were included (mean age 72±7.6 years, 86% male) with 69 juxta renal aneurysms (62.2%), 23 para-renal aneurysms (20.7%), and 19 proximal EL after EVAR (17.1%). The mean follow-up was 28.1±16.2 months. No primary type Ia EL was observed at discharge. During follow-up, 1 patient (<1%) developed a secondary type Ia EL, which was successfully managed with the placement of an aortic cuff. The PND was observed in 40 patients (36%), while significant stent-graft migration was observed in 1 patient (0.9%) without any impact on proximal sealing or bridging-stents. Effective OS was the only independent predictor of PND in the multivariable analysis (odds ratio [OR]=1.193; 95% confidence interval [CI]= 1.104-1.288; p<0.001). Seven patients (6.3%) underwent prophylactic PSZ-related reintervention, at a mean interval of 26.4±16.9 months following the index procedure, to prevent the occurrence of a type Ia EL. CONCLUSION: The proximal sealing system of the Anaconda fenestrated stent-graft's demonstrates encouraging mid-term performance, with a low incidence of type Ia EL observed over more than 2 years of follow-up. The PND related to stent-graft OS is common but generally stabilizes after the first year. Beyond this point, any progression should be attributed to the underlying aortic disease. In such cases, proximal extension of the sealing zone can be performed with satisfactory outcomes.Clinical ImpactThis study provides the first dedicated mid-term evaluation of the proximal sealing system of the Anaconda® fenestrated stent-graft in complex abdominal aortic aneurysms. When implanted in a healthy supraceliac landing zone with adequate effective oversizing, the device offers durable proximal sealing with a low incidence of type Ia endoleak. These findings support confident use of the Anaconda® platform in challenging anatomies, while emphasizing the importance of careful deployment to avoid use of the repositioning system and the associated risk of ring tilting. The study also highlights that early proximal neck dilatation is common but usually stabilizes, justifying tailored surveillance and allowing prophylactic proximal extension when necessary.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Bordet M, Oliny A, Tessely H, et al. Mid-term Results of the Anaconda Fenestrated Stent-Graft Proximal Sealing System in the Exclusion of Complex Abdominal Aortic Aneurysms. J Endovasc Ther. 2026. PMID: 41545023. doi:10.1177/15266028251406781

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。